Agenus reported $73.54M in Cash and Equivalent for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acceleron Pharma XLRN:US $ 336.46M 0.26M
Amgen AMGN:US $ 11969M 5339M
AstraZeneca AZN:LN 7067M 8500M
Bristol Myers Squibb BMY:US $ 13540M 2516M
Celldex Therapeutics CLDX:US $ 72.18M 28.74M
Chemocentryx CCXI:US $ 93.73M 16.52M
Dicerna Pharmaceuticals DRNA:US $ 165.76M 55.45M
Dynavax Technologies DVAX:US $ 246.35M 116.74M
Eli Lilly And LLY:US $ 3788.2M 568.2M
Flexion Therapeutics FLXN:US $ 136.82M 29.2M
Genocea Biosciences GNCA:US $ 48.91M 11.49M
Gilead Sciences GILD:US $ 6837M 1944M
GlaxoSmithKline GSK:LN 3453M 50M
Glaxosmithkline GSK:US $ 3453M 50M
Immunogen IMGN:US $ 245.76M 6.22M
Intrexon XON:US $ 41.73M 5.32M
Jiangsu Hengrui Me. 600276:CH CH 14.33B 1.9B
Karyopharm Therapeutics KPTI:US $ 137.4M 3.91M
Macrogenics MGNX:US $ 190.53M 1.56M
Merck MRK:GR € 1523M 302M
Northwest Biotherapeutics NWBO:US 3.84M 78K
Novartis NOVN:VX SF 7211M 2094M
Novavax NVAX:US $ 366.24M 128.21M
Regeneron Pharmaceuticals REGN:US $ 3432.4M 1360.2M
Rigel Pharmaceuticals RIGL:US $ 30.4M 54.42M
Sangamo Biosciences SGMO:US $ 176.95M 7.08M
Veracyte VCYT:US $ 164.03M 163.52M
YTE INCY:US $ 1999.02M 201.44M